Publications

The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity

Nature Communications

Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope

Mass spectrometry–driven exploration reveals nuances of neoepitope-driven tumor rejection

Cancer Immunology

CD11c+ MHCIIlo GM-CSF-bone marrow-derived dendritic cells act as antigen donor cells and as antigen presenting cells in neoepitope-elicited tumor immunity against a mouse fibrosarcoma

Bacterial ghost of avian pathogenic E. coli (APEC) serotype O78:K80 as a homologous vaccine against avian colibacillosis

Neoepitopes as cancer immunotherapy targets: key challenges and opportunities

Immunological Methods

Tumor Control Index as a new tool to assess tumor growth in experimental animals

The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity

Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope

Nature Communications 2021

Mass spectrometry–driven exploration reveals nuances of neoepitope-driven tumor rejection

JCI Insight 2019

CD11c+ MHCIIlo GM-CSF-bone marrow-derived dendritic cells act as antigen donor cells and as antigen presenting cells in neoepitope- elicited tumor immunity against a mouse fibrosarcoma

Cancer Immunology, Immunotherapy 2018

Neoepitopes as cancer immunotherapy targets: key challenges and opportunities

Immunotherapy 2017

Tumor Control Index as a new tool to assess tumor growth in experimental animals

Immunological Methods 2017

Bacterial ghost of avian pathogenic E. coli (APEC) serotype O78:K80 as a homologous vaccine against avian colibacillosis